European journal of nuclear medicine and molecular imaging

2026

A phase I study to evaluate the dosimetry and safety of [89Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis.

doi:10.1007/s00259-026-07853-y ·PMID:41872337

PURPOSE: Misfolded superoxide dismutase-1 (mSOD1) is an abnormal protein observed in amyotrophic lateral sclerosis (ALS) and constitutes a therapeutic target. The present study evaluated the biodistribution, dosimetry, and safety of a new a…

article 2026

FAP expression in deep and superficial endometriosis: Association with MRI and transvaginal ultrasound visibility

doi:10.1007/s00259-026-08189-3 ·PMID:42758302

PURPOSE: Fibroblast activation protein (FAP) is expressed in the fibroinflammatory stroma of endometriosis, but its relationship to conventional imaging visibility is unknown. We evaluated FAP expression in deep endometriosis (DE) and super…

other 2025

[68Ga]Ga-FAPI-04 PET/CT in a patient with endometriosis: a potential game changer?

doi:10.1007/s00259-025-07252-9 ·PMID:40183952

2021

The false myth of "iodine allergy" also in nuclear medicine.

doi:10.1007/s00259-021-05356-6 ·PMID:34585268

article 2020

18F-FDG simultaneous PET/MR findings of a malignant transformation and metastases of abdominal wall endometriosis

doi:10.1007/s00259-020-04761-7 ·PMID:32335705

other 2007

Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL

doi:10.1007/s00259-006-0191-6 ·PMID:17021817

PURPOSE: To evaluate the feasibility of using (99m)Tc-glutamate peptide-estradiol in functional imaging of estrogen receptor-positive [ER(+)] diseases. METHODS: 3-Aminoethyl estradiol (EDL) was conjugated to glutamate peptide (GAP) to yiel…